Daily statistics
"Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator ..."
about Innate Pharma S.A.
Notified: 05:47 EDT at $6.54
"Zynga Enters Into Agreement to Acquire Istanbul-based Peak, Creator of Top Charting Mobile Franchises Toon Blast and Toy Blast"
about Zynga Inc.
Notified: 07:00 EDT at $9.36
"Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced ..."
about Aileron Therapeutics, Inc..
Notified: 07:01 EDT at $1.79
"Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVI..."
about Altimmune, Inc.
Notified: 07:01 EDT at $10.48
"Baudax Bio Secures $50 Million Credit Facility"
about Baudax Bio, Inc.
Notified: 07:01 EDT at $4.25
"Akcea announces approval for reimbursement of TEGSEDI® (inotersen) in Portugal for treatment of hereditary transthyretin amyloidosis with po..."
about Akcea Therapeutics, Inc.
Notified: 07:02 EDT at $14.90
"Avista Capital Partners and VHC Investco Acquire Vision Healthcare NV in a Transaction Valued at $336 Million"
about Avista Corporation
Notified: 07:02 EDT at $39.08
"Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19"
about Proteostasis Therapeutics..
Notified: 07:02 EDT at $1.44
"Compugen Announces FDA Clearance of IND Application for Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibb's Opdivo® (Ni..."
about Compugen Ltd.
Notified: 07:02 EDT at $15.74
"Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial"
about Biomerica, Inc.
Notified: 07:38 EDT at $6.35
"NanoVibronix Expands License Agreement for UroShield® and PainShield™ with Existing Distributor to Include Canada and Turkey"
about NanoVibronix, Inc.
Notified: 08:00 EDT at $2.31
"Novus Therapeutics Announces Topline Results of Phase 2a Clinical Trial of OP0201 in Acute Otitis Media"
about Novus Therapeutics, Inc.
Notified: 08:32 EDT at $1.27
"Revance and Mylan to Advance Development Program for Biosimilar to BOTOX®"
about Revance Therapeutics, Inc..
Notified: 08:32 EDT at $20.90
"Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays"
about Anixa Biosciences, Inc.
Notified: 08:33 EDT at $2.97
"Diodes Incorporated Announces New $670 Million Credit Facility in Next Step of Lite-On Semiconductor Acquisition"
about Diodes Incorporated
Notified: 09:02 EDT at $48.64
"AXIM® Biotechnologies Begins Pre-Clinical Pharmacokinetic Animal Drug Studies on its Cancer Drug Compound SPX-1009"
about SPX Corporation
Notified: 09:02 EDT at $39.98
"Natera Launches Quantification Technique to Enhance Prospera™ Test Precision; Initiates PEDAL Study for New Insights"
about Natera, Inc.
Notified: 09:11 EDT at $43.85
"Orgenesis to Collaborate with The Edith Wolfson Medical Center to Conduct Clinical Study Using Orgenesis’ Proprietary POCare Technologies fo..."
about Orgenesis Inc.
Notified: 09:38 EDT at $7.31
"Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal"
about Kazia Therapeutics Limite..
Notified: 10:31 EDT at $3.18
"Bluware Signs New Agreement with BP to Support Innovative Deep Learning Workflow in Subsurface Data Interpretation"
about BP p.l.c.
Notified: 11:01 EDT at $23.52
"AVEO Oncology Announces FDA Acceptance for Filing of a New Drug Application for Tivozanib as a Treatment of Relapsed or Refractory Renal Cel..."
about AVEO Pharmaceuticals, Inc..
Notified: 13:16 EDT at $8.60
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.
